COVID-19 Vaccine Development

Our Science
COVID-19 Vaccine Development

COVID-19 Vaccine Development

Rapid progress on the path to develop, test and manufacture a vaccine

COVID-19 INFORMATION AND RESOURCES

Your Health
man_lab_dark_380x500.png
man_lab_dark_1000x450_0.jpg

COVID-19 INFORMATION AND RESOURCES

Current information on our scientific progress to bring forward a safe and effective vaccine to help protect against the novel coronavirus.

Perspectives on COVID-19 from Mace Rothenberg, M.D.

Your Health
mace_2019_380x500_1.png
mace_2019_1000x450.jpg

Perspectives on COVID-19 from Mace Rothenberg, M.D.

Mace Rothenberg, M.D., Pfizer’s CMO shares some tips about new information and research when it comes to COVID-19.

UNDERSTANDING SOCIAL DISTANCING: HOW FAR IS ENOUGH?

Your Health
social_distancing_image_790x500.png
social_distancing_image_1000x450.jpg

UNDERSTANDING SOCIAL DISTANCING: HOW FAR IS ENOUGH?

What is social distancing, and why practice it?

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

THE ANTIGEN: #COVID19 PODCAST

Podcasts
the_antigen_image_380x700.png
the_antigen_image_1000x450.jpg

THE ANTIGEN: #COVID19 PODCAST

Season 2 of The Antigen podcast focuses on COVID-19, Pfizer’s response to the crisis and more.

Maintaining Positivity: A Mother and Daughter’s Perspective on Chronic Pain Due to Osteoarthritis

Your Health
Maintaining_Positivity_790x500.png
Maintaining_Positivity_1000x450.jpg

Maintaining Positivity: A Mother and Daughter’s Perspective on Chronic Pain Due to Osteoarthritis

In recognition of Pain Awareness Month, Ann and her daughter Elizabeth (Lizzie) Sullivan sat down with Grace Whiting, President & CEO of the National Alliance for Caregiving, to discuss the impact that chronic pain due to OA can have.

Latest News

Company has 89 pipeline projects spread across 6 targeted therapeutic areas with 4 programs in registration and 23 in Phase 3 27 key programs highlighted, including assets that could potentially contribute revenue by 2025 and others in the 2026-2028 time frame Pipeline contributes to the Company’s expectation of at least 6% revenue CAGR over the next five years – and delivery of longer-term topline growth beyond that period Major revenue contributions through 2025 anticipated from Oncology,…